SEATTLE, April 19, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global knee surgeries and arthroplasty pain management therapeutics market is estimated to be valued at US$ 4,211.7 million in 2022 and expected to exhibit a CAGR of 4.8% over the forecast period (2022-2030).
Key Trends and Analysis of the Global Knee Surgeries and Arthroplasty Pain Management Therapeutics Market:
An increase in the number of knee surgeries and arthroplasty is expected to drive the market growth over the forecast period. For instance, according to data published by the Canadian Institute for Health Information in June 2021, more than 75,000 knee replacements were performed in Canada.
Key players operating in the market are focusing on the development of novel therapeutics for the treatment of knee surgeries and arthroplasty pain management, which is expected to drive the market growth over the forecast period
For instance, in May 2021, Allay Therapeutics, a pharmaceutical company offers analgesic products for post-surgical pain management and recuperation made an announcement of the first ever clinical data which shows non-opioid pain relief. The data was validated from a Phase 1b/2a clinical study of Allay’s first candidate, ATX-101, in improvement to medicate pain after total knee arthroplasty surgery or total knee arthroplasty (replacement). ATX-101 is a small dissolvable product incorporating the approved local analgesic bupivacaine.
Request for Sample copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4998
Key companies in the market are focusing on regulatory approvals, which is expected to drive the market growth over the forecast period
For instance, in March 2020, GlaxoSmithKline plc, a science-led global healthcare company, announced the approval of Advil Dual Action with Acetaminophen by the U.S. Food and Drug Administration, as an over-the-counter (OTC) product for pain relief. Advil Dual Action gives relief for various symptoms and is the major formulation that merges acetaminophen and ibuprofen – two strong ingredients indicated for over-the-counter pain relief that work in different ways.
Key Market Takeaways:
The global knee surgeries and arthroplasty pain management therapeutics market is expected to exhibit a CAGR of 4.8% over the forecast period, owing to increasing research and development. In April 2021, Pfizer Inc., an American multinational biotechnology and pharmaceutical company, and Eli Lilly and Company, an American pharmaceutical company, announced top-line results from a Phase 3 study evaluating tanezumab 5 mg and 2.5 mg. The aim of the study was to correlate the 16-week efficacy of tanezumab and long-term joint safety relative to nonsteroidal anti-inflammatory drugs in patients with moderate-to-severe osteoarthritis of knee.
The increasing number of arthroplasties is expected to drive the segment growth over the forecast period. For instance, according to an article published by RheumatologyAdvisor.com, that offers healthcare professionals a comprehensive knowledge base of practical rheumatology information and resources, in May 2019, researchers analyzed data from the U.S. National Inpatient Sample from 2000 to 2014 with Census Bureau data to develop projections for the use of total hip arthroplasty and total knee arthroplasty from 2020 to 2040. Based on their review of the data, researchers predicted that the annual number of total knee arthroplasty is predicted to increase by 56% in 2020 to 1,065,000 replacements; by 110% in 2025 to 1,272,000 replacements; by 182% in 2030 to 1,921,000 replacements; and by 401% in 2040 to 3,416,000 replacements in the U.S.
North America is expected to exhibit a high growth rate in the global knee surgeries and arthroplasty pain management therapeutics market during the forecast period, owing to the increasing awareness about joint replacement surgery. For instance, in October 2020, Zimmer Biomet Holdings, Inc., a global leader in musculoskeletal healthcare, launched ‘Don't Let Pain Gain on You’, a multimedia campaign to inform and empower people who have delayed joint replacement surgery to have a conversation with their healthcare professional about confidently moving forward with their procedure. The campaign is informed by the results of a new U.S. survey that reveals nearly half (48%) of joint replacement surgery candidates have postponed treatment due to fears stemming from the COVID-19 pandemic.
Competitive Landscape:
Key players operating in the global knee surgeries and arthroplasty pain management therapeutics market include Pfizer Inc, Allay Therapeutics, Mallinckrodt, Johnson & Johnson, Zydus Cadila Healthcare Ltd., Novartis AG, Purdue Pharma, Delphis Pharmaceutical, Taj Pharmaceuticals Limited, GlaxoSmithKline plc, AbbVie Inc., and Aurobindo Pharma.
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4998
Market Segmentation:
- Global Knee Surgeries And Arthroplasty Pain Management Therapeutics Market, By Drug:
- Acetaminophen
- COX-2 inhibitors
- Opioids
- Non-steroidal Anti-inflammatories
- Ketamine
- Others
- Global Knee Surgeries And Arthroplasty Pain Management Therapeutics Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Knee Surgeries And Arthroplasty Pain Management Therapeutics Market, By Region:
- North America
-
-
- By Country
- U.S.
- Canada
- By Country
-
-
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Country
- Europe
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- By Country
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- By Country
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- By Country
- Africa
- By Country/Region
- South Africa
- Central Africa
- North Africa
- By Country/Region
- Latin America
Related Market Intelligence Reports:
Partial Knee Arthroplasty Market, by Implant Type (Fixed Bearing, Mobile Bearing, Medical Pivot, Posterior Cruciate Ligament Retaining (Non-constrained), Posterior Cruciate Ligament Substituting (Constrained), and Gender Specific), by End User (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2021-2028
Knee Replacement Market, by Procedure (Total Knee Replacement, Partial Knee Replacement, Kneecap Replacement, and Revision Knee Replacement), by Implant Type (Fixed-bearing Implants, Mobile-bearing Implants, Medial Pivot Implants, and Others), by Material (Metal-on-Plastic, Ceramic-on-Plastic, Ceramic-on-Ceramic, and Metal-on-Metal), by End User (Hospital, Orthopedic Clinics, Ambulatory Surgery Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
